Biogen beats quotes on cost cuts and brand-new drugs like Leqembi, however revenue outlook fails
Biogen anticipates Leqembi and new rare disease and depression treatments to assist balance out income lost from several sclerosis items.
Source
Biogen anticipates Leqembi and new rare disease and depression treatments to assist balance out income lost from several sclerosis items.
Source
